ATMP classification: the EMA spells out how decisions are made
This article was originally published in RAJ Devices
Executive Summary
The European Medicines Agency has adopted a document that explains an optional procedure under which sponsors can request a scientific recommendation from the agency’s Committee for Advanced Therapies in order to establish whether a product should be classified as an advanced therapy medicinal product1.